Should cancers that are not traditionally associated with Lynch syndrome or MSI-H status be tested? This expert thinks so.
The 17th international Thyroid Cancer Survivors' Conference will be held Oct. 17 to 19, 2014 in Denver.
Dr. Omid Hamid discusses combining targeted drugs and immunotherapy, the role of surgery and ongoing research efforts in melanoma.
With the overall number of deaths from cancer in decline over the past 20 years, advocacy groups like the National Ovarian Cancer Coalition are doing their part to reduce this number further.
Because they have been found to be effective in the treatment of many types of cancer, including melanoma, immunotherapy drugs like anti-PD-1 agents and anti-CTLA4 therapies should not be discounted because of their toxicities.
The side effects of colorectal cancer and its treatment—which span beyond fertility issues—require constant renegotiation and reframing of what it means to be me.
An Extraordinary Healer Essay honoring Karen Ebert, BSN, RN, OCN [ Trinitas Comprehensive Cancer Center in Elizabeth, New Jersey ]
It is important that patients and their loved ones stay hopeful during the ovarian cancer journey. We asked attendees of the 2018 NOCC Annual Conference how they keep positive.
An Extraordinary Healer essay honoring ROSS FOOTE, OCN [JACK C. MONTGOMERY VA MEDICAL CENTER, MUSKOGEE, OKLAHOMA]
Sarah Sciortino, MSW, LSW, Oncology Psychosocial Support Services Program Coordinator at University of Chicago Hospital, discusses the unique concerns that younger patients with ovarian cancer can face.
This sidebar to the feature “Cancer for the long haul” written by Wendy Harpham, MD, discusses her recurring non-Hodgkin’s lymphoma.
When I learned that lung cancer is the number one cancer killer in the United States, but one of the lowest funded for research, it made me angry.
Day after day, patients come in to receive chemotherapy treatment, passing rooms with warning signs and hospital staff in protective isolation gear. They want to know they are safe.
Linda R. Duska, gynecologic oncologist, University of Virginia, discusses the Foundation for Women's Cancer.
We spoke with Oeffinger during the 2016 Cancer Survivorship Symposium in mid-January.
Patients with PV tend to be very symptomatic, but Jakafi can help.
One of three finalist essays for the 2008 CURE Extraordinary Healer Award Contest.
“Although more evidence is needed before changing clinical practice, these are highly promising results, suggesting that (Bavencio) could prevent patients with chemo-resistant disease from the severe toxicity of chemotherapy combinations.”
An expert discusses the exciting new developments extending survival in the evolving ovarian cancer treatment space.
New Initiative Aims to Foster Informed Discussions Between Newly Diagnosed Lung Cancer Patients, Caregivers and Their Healthcare Team
I am privileged and honored to nominate Miami Cancer Institute (MCI) pediatric oncology nurse Alicia De Pazos, RN, CPHON, for the 2019 CURE® Extraordinary Healer® Award. Alicia has been a pediatric oncology nurse for over 32 years. In that time, she has held many different positions — all in the pediatric oncology setting.
One oncology nurse developed the BARF scale so her young patients could better communicate how they were feeling.